A major discovery in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor inhibitor protein is frequently disabled in several types of tumors, causing https://bookmarkspecial.com/story22133183/vhh-fragments-reactivate-tumor-suppressor-p53-new-promising-pathway-for-cancer-management